Baotou Dongbao bio-tech announced that the company plans to acquire the remaining 9.64 million shares of Yiqing bio-tech held by Qingdao Gon Technology and Deyu bio-tech (accounting for 40% of the total share capital of Yiqing bio-tech) for a transaction price of 0.232 billion yuan. After the transaction is completed, Baotou Dongbao bio-tech will hold 100% of the shares of Yiqing bio-tech. Qingdao Gon Technology and Deyu bio-tech are both related entities of the company, and this transaction constitutes a related party transaction.
东宝生物：拟2.32亿元收购益青生物剩余40%股份
Baotou Dongbao Bio-tech plans to acquire the remaining 40% stake of Yi Qing Bio-tech for 0.232 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.